Home › Funds › SHENKMAN CAPITAL MANAGEMENT INC › HAE

SHENKMAN CAPITAL MANAGEMENT INC position in HAE

HAEMONETICS CORP MASS · Health Care

SHENKMAN CAPITAL MANAGEMENT INC reported holding 1,323,000 shares of HAE (HAEMONETICS CORP MASS) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.31% of its reported portfolio and ranking #43 among its reported holdings. SHENKMAN CAPITAL MANAGEMENT INC has disclosed HAE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.32M sh
Reported value held$1.52M
Portfolio Weight0.31%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SHENKMAN CAPITAL MANAGEMENT INC's HAE position evolved

SHENKMAN CAPITAL MANAGEMENT INC first disclosed a stake in HAE in Q2 2025 at 12,053,000 shares (US$12.4M). Across 6 filings, SHENKMAN CAPITAL MANAGEMENT INC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,323,000 shares valued at US$1.5M. Notable position changes include a 89% trim in Q4 2025 (shares fell 30% over the following quarter), a 42% increase in Q1 2026 (shares rose 33% over the following quarter), a 29% trim in Q2 2026 (shares rose 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 12.05M $12.39M New
Q3 2025 12.14M $11.56M Add
Q4 2025 1.32M $1.38M Reduce
Q1 2026 1.87M $1.81M Add
Q2 2026 1.32M $1.35M Reduce
Q3 2026 1.32M $1.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HAE and 13F data

HAE (HAEMONETICS CORP MASS) is a Health Care company. 24 other funds we track also report a position in HAE — the largest reported positions include ARIEL INVESTMENTS, LLC (US$228.9M), River Road Asset Management, LLC (US$110.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HAE

All HAE fund holders →

FAQ

How long has SHENKMAN CAPITAL MANAGEMENT INC held HAE?

SHENKMAN CAPITAL MANAGEMENT INC has disclosed HAE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is SHENKMAN CAPITAL MANAGEMENT INC's current position in HAE?

As of Q3 2026, SHENKMAN CAPITAL MANAGEMENT INC holds 1.32M shares of HAE (HAEMONETICS CORP MASS), valued at $1.52M, representing 0.31% of its reported portfolio and ranking #43.

Has SHENKMAN CAPITAL MANAGEMENT INC been buying or selling HAE?

In the latest 13F filing (Q3 2026), SHENKMAN CAPITAL MANAGEMENT INC held unchanged its position in HAE.

Which other funds hold HAE?

Other major institutional holders of HAE include ARIEL INVESTMENTS, LLC, River Road Asset Management, LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.